FIELD: chemical-pharmaceutical industry.
SUBSTANCE: Sygethinum containing medicine for local and external application is offered. It is produced in liquid form, e.g. as suspensions or emulsions or in the soft medicinal form, e.g. as cream, ointment, or gel, or in compact soft medicinal form, e.g. as suppositories or capsules for peranum or vaginal application. Medicine contains perfluorogranic emulsion or its mixture with hyperosmolar hydrophilic substances and water as base material.
EFFECT: provides high bioavailability of medicine without crippling of cutaneous covering, increases therapeutic effect of Sygethinum.
3 cl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LOCAL AND EXTERNAL SYGETHIN-BASED PHARMACEUTICAL COMPOSITION FOR MENOPAUSAL DISORDERS PREVENTION AND TREATMENT | 2007 |
|
RU2356548C1 |
| LOCAL AND EXTERNAL SYGETHIN-BASED PHARMACEUTICAL COMPOSITION APPLIED IN MENOPAUSAL DISORDERS | 2007 |
|
RU2360670C1 |
| PHARMACEUTICAL PREPARATION FOR EXTERNAL AND LOCAL APPLICATION, BASED ON SYGETHIN | 2007 |
|
RU2363461C2 |
| PHARMACEUTICAL COMPOSITION FOR LOCAL AND EXTERNAL APPLICATION WHEN TREATING TRAUMATIC AND POST-OPERATION INJURIES OF PERIPHERAL NERVOUS SYSTEM | 2007 |
|
RU2369387C2 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL USE, BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2348400C1 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION ON BASIS OF LOW-MOLECULAR INDUCTOR OF INTERFERON | 2007 |
|
RU2352330C1 |
| LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
| STEPHAGLABRIN-BASED PHARMACEUTICAL COMPOSITION OF LOCAL AND EXTERNAL APPLICATION FOR TREATMENT OF TRAUMATIC AND POST-OPERATION INJURY OF PERIPHERAL NERVOUS SYSTEM | 2007 |
|
RU2371172C2 |
| ANTIBACTERIAL AND NECROLYTIC LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367469C2 |
| ANTIBACTERIAL AND NECROLYTIC EXTERNAL AND LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367457C2 |
